Trials / Conditions / Immune-Mediated Colitis
Immune-Mediated Colitis
3 registered clinical trials studyying Immune-Mediated Colitis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis NCT06899789 | Fondazione IRCCS Policlinico San Matteo di Pavia | — |
| Terminated | Tofacitinib for the Treatment of Refractory Immune-related Colitis from Checkpoint Inhibitor Therapy- TRICK St NCT04768504 | Khashayar Esfahani | Phase 2 |
| Unknown | Vedolizumab for Immune Mediated Colitis NCT04797325 | University of Copenhagen | Phase 2 |